Literature DB >> 1612744

Legionella pneumophila lipopolysaccharide activates the classical complement pathway.

C S Mintz1, D R Schultz, P I Arnold, W Johnson.   

Abstract

Legionella pneumophila is a gram-negative bacterium capable of entering and growing in alveolar macrophages and monocytes. Complement and complement receptors are important in the uptake of L. pneumophila by human mononuclear phagocytes. The surface molecules of L. pneumophila that activate the complement system are unknown. To identify these factors, we investigated the effects of L. pneumophila lipopolysaccharide (LPS) on the classical and alternative complement pathways of normal human serum by functional hemolytic assays. Although incubation of LPS in normal human serum at 37 degrees C resulted in the activation of both pathways, complement activation proceeded primarily through the classical pathway. Activation of the classical pathway by LPS was dependent on natural antibodies of the immunoglobulin M class that were present in various quantities in sera from different normal individuals but were absent in an immunoglobulin-deficient serum obtained from an agammaglobulinemic patient. Additional studies using sheep erythrocytes coated with LPS suggested that the antibodies recognized antigenic sites in the carbohydrate portion of LPS. The ability of LPS to interact with the complement system suggests a role for LPS in the uptake of L. pneumophila by mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612744      PMCID: PMC257233          DOI: 10.1128/iai.60.7.2769-2776.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Immunologic diversity among serogroup 1 Legionella pneumophila urinary antigens demonstrated by monoclonal antibody enzyme-linked immunosorbent assays.

Authors:  R B Kohler; C Wilde; W Johnson; J Joly; L J Wheat; R Baker; M Misfeldt
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

2.  The separation of nine components and two inactivators of components of complement in humansserum.

Authors:  D H Vroon; D R Schultz; R M Zarco
Journal:  Immunochemistry       Date:  1970-01

3.  Interactions of virulent and avirulent Legionella pneumophila with human polymorphonuclear leukocytes.

Authors:  J T Summersgill; M J Raff; R D Miller
Journal:  Microb Pathog       Date:  1988-07       Impact factor: 3.738

Review 4.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica.

Authors:  E Wachter; V Brade
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Chemical composition of a lipopolysaccharide from Legionella pneumophila.

Authors:  A Sonesson; E Jantzen; K Bryn; L Larsson; J Eng
Journal:  Arch Microbiol       Date:  1989       Impact factor: 2.552

7.  Serospecific antigens of Legionella pneumophila.

Authors:  S Otten; S Iyer; W Johnson; R Montgomery
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

8.  Membrane proteins of legionellaceae. I. Membrane proteins of different strains and serogroups of Legionella pneumophila.

Authors:  W Ehret; G Ruckdeschel
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1985-07

9.  Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; R A Hatch; K A Joiner
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  Effects of cytochalasin D and methylamine on intracellular growth of Legionella pneumophila in amoebae and human monocyte-like cells.

Authors:  C H King; B S Fields; E B Shotts; E H White
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  9 in total

1.  Antibody-independent binding of complement component C1q by Legionella pneumophila.

Authors:  C S Mintz; P I Arnold; W Johnson; D R Schultz
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 2.  Complement system in lung disease.

Authors:  Pankita H Pandya; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

3.  Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14.

Authors:  B Neumeister; M Faigle; M Sommer; U Zähringer; F Stelter; R Menzel; C Schütt; H Northoff
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Acute lung injury induced by lipopolysaccharide is independent of complement activation.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Stephanie R McGuire; Laszlo M Hoesel; Kyros Ipaktchi; Firas S Zetoune; J Vidya Sarma; Lin Leng; Markus S Huber-Lang; Thomas A Neff; Richard Bucala; Peter A Ward
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

5.  C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury.

Authors:  Ruobing Wang; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  Am J Respir Cell Mol Biol       Date:  2016-11       Impact factor: 6.914

6.  Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups.

Authors:  Mohammad Adil Khan; Natalie Knox; Akriti Prashar; David Alexander; Mena Abdel-Nour; Carla Duncan; Patrick Tang; Hajera Amatullah; Claudia C Dos Santos; Nathalie Tijet; Donald E Low; Christine Pourcel; Gary Van Domselaar; Mauricio Terebiznik; Alexander W Ensminger; Cyril Guyard
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

7.  Virulence properties of the legionella pneumophila cell envelope.

Authors:  Olga Shevchuk; Jens Jäger; Michael Steinert
Journal:  Front Microbiol       Date:  2011-04-25       Impact factor: 5.640

8.  Population analysis of Legionella pneumophila reveals a basis for resistance to complement-mediated killing.

Authors:  Bryan A Wee; Joana Alves; Diane S J Lindsay; Ann-Brit Klatt; Fiona A Sargison; Ross L Cameron; Amy Pickering; Jamie Gorzynski; Jukka Corander; Pekka Marttinen; Bastian Opitz; Andrew J Smith; J Ross Fitzgerald
Journal:  Nat Commun       Date:  2021-12-09       Impact factor: 17.694

9.  Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila.

Authors:  E Lüneberg; U Zähringer; Y A Knirel; D Steinmann; M Hartmann; I Steinmetz; M Rohde; J Köhl; M Frosch
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.